Ivy Brain Tumor Center, SonALAsense and Insightec Announce the First Patient Dosed in First-in-Human Clinical Trial of Noninvasive Sonodynamic Therapy for the Treatment of Brain Cancer
30 mars 2021 08h00 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, March 30, 2021 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, has...
First Patient Treated in Ivy Brain Tumor Center’s Phase 0 Clinical Trial of Pamiparib in Newly Diagnosed and Recurrent Glioblastoma
10 mars 2021 09h32 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, March 10, 2021 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute has announced the first patient has been treated in a Phase 0 clinical trial of pamiparib...
Akesis Galaxy® RTi SRS System Receives FDA Clearance
10 mars 2021 08h00 HE
|
Akesis
High-Precision Intracranial Gamma System to Treat Brain Diseases and Brain Cancer Has Integrated, Real-Time Imaging CONCORD, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- The Akesis...
Retired Cancer Doctor, Edward Arenson MD CWSP, Chronicles Inspiring 50-Year Career in Compelling New Memoir
25 janv. 2021 06h15 HE
|
XlibrisUS
DENVER, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Now at the end of his rich medical career, Edward Arenson MD CWSP, is sharing the touching and candid stories of his brave young patients as well as paying...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent FDA Approval of IND Application
28 déc. 2020 08h00 HE
|
CNS Pharmaceuticals, Inc.
HOUSTON, Dec. 28, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade
17 déc. 2020 11h00 HE
|
DelveInsight Business Research LLP
Los Angeles, USA, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Glioblastoma Multiforme Pipeline Expected to Offer Myriad of Novel Therapies in the Next Decade Glioblastoma Multiforme Clinical Trial Analysis...
Ivy Brain Tumor Center Initiates Phase 0 Clinical Trial with BeiGene for Newly Diagnosed and Recurrent Glioblastoma
16 déc. 2020 07h00 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, Dec. 16, 2020 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute today announced the opening of a Phase 0 clinical trial for patients with newly diagnosed...
InvestorBrandNetwork Announces Gamechangers LIVE Interview with CNS Pharmaceuticals Inc. Chairman & CEO John Climaco
09 déc. 2020 09h00 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- via InvestorWire — InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
CNS Pharmaceuticals Featured in Syndicated Broadcast Covering Recent Announcements for Glioblastoma Multiforme (GBM) Therapy
24 nov. 2020 08h00 HE
|
CNS Pharmaceuticals, Inc.
HOUSTON, Nov. 24, 2020 (GLOBE NEWSWIRE) -- via InvestorWire – CNS Pharmaceuticals, Inc. (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary...
Ivy Brain Tumor Center Welcomes Biostatistician to Phase 0 Clinical Trials Program
29 sept. 2020 08h00 HE
|
Ivy Brain Tumor Center
PHOENIX, Ariz., Sept. 29, 2020 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute is pleased to announce the addition of Wonsuk Yoo, PhD, as associate professor of...